No Data
No Data
No Data
No Data
No Data
Open Letter to ViewRay Customers, Service, Software Engineers and Suppliers—Let's Preserve ViewRay Technology
In light of ViewRay Systems recent announcement that it would close its doors on October 25, 2023, Dr. Suthanthiran, President/Founder of TeamBest Global Companies (TBG) and Best Cure Foundation, is encouraging all to
BusinesswireOct 19, 2023 05:03
Letter to ViewRay Lenders/Investment Bankers and Customers From Krishnan Suthanthiran, President/Founder of TeamBest Global Companies
Since the announcement regarding the closing of ViewRay on October 25, 2023, competitors have raced to decommission the ViewRay Systems, replacing them with their own products by establishing relationships with
BusinesswireOct 17, 2023 21:04
Open Letter to ViewRay Customers From Krishnan Suthanthiran, President/Founder of TeamBest Global Companies
WASHINGTON--(BUSINESS WIRE)--TeamBest Global Companies (TBG) have been in business since 1951—over 70 years—with many innovations in Brachytherapy, Teletherapy, IMRT treatment planning software, Heavy
BusinesswireOct 13, 2023 22:46
Viewray (VRAY.US) executives sold 89,900 common shares worth approximately $6,293.07
It was reported on July 27 that according to documents disclosed by the US Securities and Exchange Commission (SEC) on July 26, $Viewray (VRAY.US) $ executive Podbelski Adam Andrew sold 89,900 common shares at an average price of 0.07 US dollars per share on July 17, with a value of about 6,293.07 US dollars. For details on the disclosing party's derivatives transactions, please refer to the table. This transaction involves another related party: Shah Sanket. Image source: SEC's official website (partial form of this incident) What is a shareholding change statement? SE
Futu NewsJul 27, 2023 05:43
News On ViewRay Inc. (VRAY) Now Under VRAYQ
News On ViewRay Inc. (VRAY) Now Under VRAYQ
Dow JonesJul 27, 2023 05:08
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers9 Meters Biopharma (NASDAQ:NMTR) stock rose 36.8% to $0.1 during Tuesday's after-market session. At the close, 9 Meters Biopharma's trading volume reached 4.7 million shares. This is 1095.7% of
BenzingaJul 26, 2023 05:32
No Data
No Data